#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	13876	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2070	664.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1423	1423	C	821	C,T	771,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	13876	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2070	664.7	0	HET	.	.	.	C451T	.	451	451	C	690	690	C	821	C,T	573,197	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25346	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3707	681.7	0	.	n	.	0	T695C	SNP	695	695	T	1096	1096	C	792	C	740	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25346	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3707	681.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2372	2372	C	797	C,A,T	734,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25346	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3707	681.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2446	2446	A	800	A	760	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25346	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3707	681.7	1	SNP	n	C2597T	0	.	.	2597	2597	C	2998	2998	C	797	C	762	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	1798	folP	855	855	100.0	folP.l15.c4.ctg.1	1501	119.2	1	SNP	p	R229S	1	.	.	685	687	AGC	1008	1010	AGC	173;175;173	A,C;G;C	163,1;166;164	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5008	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3520	141.8	1	SNP	p	S91F	1	.	.	271	273	TTC	550	552	TTC	158;158;156	T;T;C	149;152;150	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5008	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3520	141.8	1	SNP	p	G95N	0	.	.	283	285	GGC	562	564	GGC	155;156;155	G;G,A;C	148;148,1;149	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5008	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3520	141.8	1	SNP	p	D95G	1	.	.	283	285	GGC	562	564	GGC	155;156;155	G;G,A;C	148;148,1;149	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	1612	mtrR	633	633	100.0	mtrR.l15.c17.ctg.1	1518	105.8	1	SNP	p	G45D	0	.	.	133	135	GGC	460	462	GGC	180;180;182	G;G;C	168;168;171	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	822	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1068	76.4	0	.	n	.	0	A197.	DEL	197	197	A	613	613	A	195	A	176	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5238	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3101	168.3	1	SNP	p	D86N	0	.	.	256	258	GAC	634	636	GAC	191;194;192	G;A,G;C	180;179,1;177	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5238	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3101	168.3	1	SNP	p	R87I	0	.	.	259	261	CGT	637	639	CGT	191;192;192	C,A;G;T	181,1;179;177	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5238	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3101	168.3	1	SNP	p	S87R	1	.	.	259	261	CGT	637	639	CGT	191;192;192	C,A;G;T	181,1;179;177	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5238	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3101	168.3	1	SNP	p	R87W	0	.	.	259	261	CGT	637	639	CGT	191;192;192	C,A;G;T	181,1;179;177	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5238	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3101	168.3	1	SNP	p	S88P	0	.	.	262	264	TCC	640	642	TCC	190;191;194	T;C;C	180;179;183	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3862	parE	1986	1986	100.0	parE.l15.c17.ctg.1	2555	149.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1526	1528	GGC	171;167;165	G;G;C	164;158;156	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3738	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2418	153.8	1	SNP	p	A311V	0	.	.	931	933	GCC	1269	1271	GCC	207;206;207	G;C;C	192;192;193	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3738	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2418	153.8	1	SNP	p	I312M	1	.	.	934	936	ATG	1272	1274	ATG	207;207;210	A;T;G	196;194;197	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3738	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2418	153.8	1	SNP	p	T316P	0	.	.	946	948	ACC	1284	1286	ACC	208;208;210	A;C;C	192;197;197	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3738	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2418	153.8	1	SNP	p	V316T	1	.	.	946	948	ACC	1284	1286	ACC	208;208;210	A;C;C	192;197;197	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3738	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2418	153.8	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1785	1787	ACC	227;228;230	A;C;C	214;222;220	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3738	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2418	153.8	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1839	1841	GCG	218;215;219	G;C,A;G	202;199,1;201	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3738	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2418	153.8	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1839	1841	GCG	218;215;219	G;C,A;G	202;199,1;201	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3738	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2418	153.8	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1962	1964	GGT	165;162;161	G;G;T	155;153;147	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3738	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2418	153.8	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1971	1973	AGC	157;152;151	A;G;C	145;140;137	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3738	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2418	153.8	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1989	1991	CCG	118;118;119	C,G;C,G;G	89,3;89,1;95	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5424	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3328	162.5	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1736	1738	CCG	197;200;199	C;C;G	169;178;174	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2378	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1688	139.2	0	.	p	.	0	M83fs	FSHIFT	247	247	A	550	550	C	172	C	157	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	276	porB1a	984	331	90.15	porB1a.l15.c30.ctg.1	1095	21.5	0	.	p	.	0	H217N	NONSYN	649	651	CAT	773	775	AAT	15;15;14	A;A;T	15;15;14	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	276	porB1a	984	331	90.15	porB1a.l15.c30.ctg.1	1095	21.5	0	.	p	.	0	D218N	NONSYN	652	654	GAT	776	778	AAT	14;14;14	A;A;T	14;14;14	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	276	porB1a	984	331	90.15	porB1a.l15.c30.ctg.1	1095	21.5	0	.	p	.	0	V226A	NONSYN	676	678	GTA	800	802	GCA	14;14;14	G;C;A	14;14;14	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	276	porB1a	984	331	90.15	porB1a.l15.c30.ctg.1	1095	21.5	0	.	p	.	0	.	MULTIPLE	700	702	ACT	823	825	GTA	15;14;14	G;T;A	14;14;14	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	276	porB1a	984	331	90.15	porB1a.l15.c30.ctg.1	1095	21.5	0	.	p	.	0	N237fs	FSHIFT	709	709	A	832	832	A	12	A	12	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2710	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1727	156.1	0	.	p	.	0	G48E	NONSYN	142	144	GGA	527	529	GAA	252;253;257	G,T;A;A	239,1;239;241	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2710	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1727	156.1	1	SNP	p	G120K	1	.	.	358	360	AAG	743	745	AAG	211;208;205	A;A;G	200;201;198	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2710	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1727	156.1	1	SNP	p	A121N	1	.	.	361	363	AAC	746	748	AAC	204;204;202	A;A;C	197;198;194	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2710	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1727	156.1	1	SNP	p	N121D	0	.	.	361	363	AAC	746	748	AAC	204;204;202	A;A;C	197;198;194	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9804	rpoB	4179	4179	99.98	rpoB.l15.c17.ctg.1	5042	193.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1090	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	1083	99.7	1	SNP	p	V57M	1	.	.	169	171	ATG	585	587	ATG	234;236;236	A;T;G	225;226;225	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
